Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per specialist: NOVARTIS
Woman and Man Max 99 years
NOVARTIS
Update Il y a 4 ans
Safety and Efficacy of QAX576 in Adults With Moderate Persistent Allergic Asthma
This study will evaluate the safety and efficacy of QAX576 against asthma attacks in adults with moderate persistent allergic asthma
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
NOVARTIS
Update Il y a 4 ans
Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide
This study is designed to provide information on feasibility and reproducibility of barostat assessments of colorectal sensory functions and compliance and their pharmacological modulation
Country
Canada
,
Sweden
,
United Kingdom
,
United States
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
NOVARTIS
Update Il y a 4 ans
Pharmacokinetic Study of LAF237 and Its Metabolites in Mild Renal Impaired Patients
This study will evaluate the pharmacokinetics of vildagliptin (LAF237) and its metabolites in patients with mild renal impairment compared to their sex, age and weigh based healthy volunte...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
NOVARTIS
Update Il y a 4 ans
Safety and Efficacy of APL180 in Healthy Volunteers and Patients With Coronary Heart Disease (CHD)
The purpose of this study is to determine: (1) the safety and pharmacokinetics of APL180 administered as a single intravenous infusion in healthy volunteers, and (2) the safety, pharmacoki...
Country
Belgium
,
Denmark
,
Israel
,
Netherlands
,
South Africa
,
United Kingdom
,
United States
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
NOVARTIS
Update Il y a 4 ans
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Type 2 Diabetes
The purpose of this study was to evaluate, in patients with Type 2 Diabetes Mellitus, whether Canakinumab can lower Glycosylated hemoglobin / hemoglobin A1c (HbA1c) and/or peak glucose lev...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
NOVARTIS
Update Il y a 4 ans
Efficacy and Tolerability of STI571 (Imatinib Mesylate) for the Treatment of Fibrosis in Patients With Systemic Sclerosis
This study will investigate the efficacy and safety of STI571 for the treatment of fibrosis in patients with systemic sclerosis. Other purposes of the study are to investigate whether STI5...
Country
Germany
,
Italy
,
Switzerland
,
United Kingdom
,
United States
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
NOVARTIS
Update Il y a 4 ans
Safety and Tolerability of Indacaterol Maleate/Mometasone Furoate Delivered Via the Twisthaler® Device After 14 Days Treatment in Patients With Mild to Moderate Asthma
This study will investigate the safety and tolerability of indacaterol maleate/mometasone furoate via the Twisthaler device after 14 days treatment in patients with mild to moderate asthma...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
NOVARTIS
Update Il y a 4 ans
An Exploratory Study of the Effects of a Single Dose of QAX576 (an Interleukin-13 Monoclonal Antibody) on Simulated Hayfever
This study will investigate whether a single dose QAX576 (an interleukin-13 monoclonal antibody) gives protection against a model of hayfever
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 3 years and 21 years
Novartis Pharma
Update Il y a 4 ans
Étude CCTL019B2202 : étude de phase 2 non randomisée visant à évaluer l’efficacité et la sécurité d’emploi du CTL019 chez des patients pédiatriques ayant une leucémie lymphoblastique aiguë de la lignée B récurrente ou réfractaire. [essai clos aux inclusions]
Les leucémies aiguës lymphoblastiques représentent environ 80% des leucémies aiguës de l’enfant. Ce sont des proliférations malignes des cellules sanguines à un stade précoce de maturation appelées bl...
Country
France
organs
Leucémies aiguës
Specialty
Pédiatrie
,
Immunothérapie - Vaccinothérapie
,
Thérapie Cellulaire
Essai clos aux inclusions
More information
Woman and Man
Between 18 years
and 99 years
Novartis Pharma
Update Il y a 4 ans
Etude PANORAMA_3 : étude de phase 2, randomisée, visant à évaluer l’efficacité et la tolérance de trois différentes doses de panobinostat en association avec le bortézomib et la dexaméthasone chez des patients ayant un myélome multiple en rechute ou réfractaire et préalablement traités par des immunomodulateurs.
Le myélome multiple est un cancer du sang rare. Il se développe à partir des cellules qui produiront les cellules sanguines, les « plasmocytes ». Ce sont des cellules du système immunitaire produisant...
Country
France
organs
Myélomes
Specialty
Thérapies Ciblées
,
Chimiothérapie
Essai ouvert aux inclusions
More information
1
2
Next